Welcome to our dedicated page for Canopy Growth SEC filings (Ticker: CGC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Canopy Growth Corporation filings document the Canadian cannabis operator’s public-company reporting, including Form 8-K disclosures for quarterly results, Regulation FD releases, material agreements, shareholder voting outcomes and executive appointments. The company’s common shares are registered on Nasdaq under CGC, and filings describe capital-structure matters including senior secured debt financing and related guarantor arrangements.
Recent material-event filings also record the completed acquisition of MTL Cannabis Corp. and formal disclosures tied to operating results in Canada Cannabis and other business activities. Governance and risk-related filings cover proxy matters, voting mechanics, clinical or regulatory disclosure categories, and updates affecting the company’s cannabis brands, medical channels and Storz & Bickel vaporization devices.
Canopy Growth Corporation has adopted a new Advance Notice By-Law, labeled By-Law No. 2, which was approved by its Board of Directors on May 26, 2026. This bylaw sets a formal process for shareholders to nominate directors at annual or special meetings.
The bylaw, which is already effective, must be submitted to shareholders for confirmation at the next annual general meeting expected in September 2026. It imposes clear deadlines, ownership thresholds and detailed disclosure requirements for any nominating shareholder, while allowing the Board to waive requirements at its discretion.
Canopy Growth Corporation is restating multiple past financial statements after identifying a non-cash technical accounting error related to certain U.S. dollar–denominated share-settled warrants. Because these warrants should have been treated as liabilities rather than equity, prior audited annual financials for fiscal years ended March 31, 2024 and 2025, and several interim quarterly results, should no longer be relied upon, and the related audit reports are also affected.
The company plans to correct this by filing a comprehensive Form 10-K for the year ended March 31, 2026, including restated figures, on June 15, 2026. Management expects the impact to be limited to balance sheet reclassifications and fair value adjustments that are non-cash and non-operational, with no change to underlying business performance. However, management expects to report a material weakness in internal control over financial reporting and has applied for a management cease trade order affecting certain directors and officers until the refiling is complete.
Canopy Growth Corp director Theresa Yanofsky reported a disposition of company shares linked to tax obligations on vested equity. On March 31, 2026, she sold 10,373 common shares at $0.93 per share, in connection with the vesting of restricted stock units granted on June 3, 2025.
After this tax-related sale, Yanofsky directly holds 53,145 common shares of Canopy Growth. The transaction reflects a routine disposition tied to RSU vesting rather than a discretionary open-market reduction of her overall stake.
ATKINS M SHAN reported open-market sale transactions in this Form 4 filing.
Canopy Growth Corp director M. Shan Atkins disposed of 2,074 common shares on March 31, 2026 at $0.93 per share. According to the disclosure, these shares were originally granted as restricted stock units and the disposition was tied to tax obligations triggered by RSU vesting.
After this tax-related share disposition, Atkins directly holds 41,390 common shares, indicating that only a small portion of her equity position was affected by this routine compensation and tax event.
BAYERN JOSEPH reported open-market sale transactions in this Form 4 filing.
Canopy Growth Corp director Joseph Bayern reported a tax-related share disposition. On March 31, 2026, he disposed of 2,658 Common Shares at $0.93 per share. A footnote explains these shares were originally granted as restricted stock units and the disposition was associated with his tax obligations upon RSU vesting. Following this transaction, he continues to hold 40,000 Common Shares directly.
Canopy Growth Corp director David Angelo Lazzarato reported a disposition of 15,624 common shares at $0.93 per share. According to the footnote, these shares were sold to satisfy tax obligations arising from the vesting of restricted stock units granted on June 3, 2025. After this transaction, he directly holds 72,048 common shares.
Canopy Growth Corporation completed its acquisition of MTL Cannabis, creating what it describes as Canada’s leading medical cannabis business by revenue. Under the arrangement, MTL shareholders received 0.32 Canopy Growth common share and $0.144 in cash per MTL share, for a total of approximately 41.2 million Canopy Growth shares and $18.5 million in cash, all in Canadian dollars.
Canopy Growth also issued 2,956,391 shares to certain former shareholders of Montreal Cannabis Medical in exchange for releasing prior obligations, with these shares subject to an 18‑month transfer restriction. The company highlights expected run‑rate synergies of about $10 million within 18 months and reiterates that integrating MTL’s profitable, cash‑generating operations supports its goal of achieving positive adjusted EBITDA during fiscal 2027. Several MTL leaders have joined Canopy Growth’s senior management, and MTL is now a wholly owned subsidiary whose shares are anticipated to be delisted from the CSE around March 16, 2026.
Canopy Growth Corporation has registered for resale up to 18,705,578 common shares issuable upon exercise of loan warrants held by certain lending investors. These warrants, issued January 8, 2026 under a senior secured loan agreement, allow holders to buy one share at US$1.30 until January 8, 2031.
The company will not receive proceeds from any resale of these shares, but would receive approximately US$24.3 million if all loan warrants are exercised for cash. As of February 4, 2026, 377,862,634 common shares were outstanding. Warrant exercises are generally limited to 4.99% ownership, with an option to increase the cap to 9.99%.
Canopy Growth Corp’s Chief Executive Officer, Luc Mongeau, reported an open-market sale of 9,376 common shares on February 11, 2026. The shares were sold at US$1.0613 per share, which equals C$1.4406 using the Bank of Canada’s February 11, 2026 exchange rate.
The filing explains that these shares had originally been granted as restricted stock units on February 11, 2025, and that the disposition was made to satisfy tax obligations arising from the RSU vesting. After this transaction, Mongeau directly owned 802,992 Canopy Growth common shares.